Safety and efficacy of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus infection genotype 1–6 and chronic kidney disease: an integrated analysis
2017 ◽
Vol 152
(5)
◽
pp. S1062-S1063
◽
2011 ◽
Vol 6
(1)
◽
pp. 369-378
◽
2015 ◽
Vol 110
◽
pp. S367
2018 ◽
Vol 64
(4)
◽